Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2003
10/07/2003US6630616 Arabidopsis MPC1 gene and methods for controlling flowering time
10/07/2003US6630584 DNA molecule of given sequence; specifically binds to given hexapeptide; use in treatment of cancer
10/07/2003US6630574 Compositions and methods for the therapy and diagnosis of lung cancer
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630443 Detecting agonists and antagonists; treating under- and overexpression
10/07/2003US6630350 Monoclonal antibodies against a human act and serine protease complex
10/07/2003US6630345 Isolated DNA soup from amino acid sequence 1 or 2
10/07/2003US6630337 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/07/2003US6630327 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630317 Methods for obtaining, identifying and applying nucleic acid sequences and (poly)peptides which increase the expression yields of periplasmic proteins in functional form
10/07/2003US6630314 Noninvasive detection of colorectal cancer and other gastrointestinal pathology
10/07/2003US6630313 Phosphatidyl serine receptors and uses thereof
10/07/2003US6630308 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630169 Particulate delivery systems and methods of use
10/07/2003US6630146 Candida albicans phosphomannan complex as a vaccine
10/07/2003US6630144 Monoclonal antibodies to Ebola glycoprotein
10/07/2003US6630140 Compositions and methods for treatment of asthma
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/07/2003CA2211204C Prostaglandin receptor dp
10/07/2003CA2132540C A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
10/07/2003CA2074153C Seroreactive regions on hpv 16 proteins e1 and e2
10/07/2003CA1341443C Human c3b/c4b receptor (cr1) (the)
10/02/2003WO2003081251A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003080856A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080821A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
10/02/2003WO2003080808A2 Novel compositions and methods in cancer
10/02/2003WO2003080676A1 Antibody against transferrin-containing immune complex, process for producing the antibody, hybridoma and immunoassay method
10/02/2003WO2003080675A2 MONOCLONAL ANTIBODY AGAINST INTERLEUKIN-13 RECEPTOR ALPHA 1 (IL-13Rα1)
10/02/2003WO2003080674A1 Antibody disulfide isomers, use thereof, and methods of analyzing same
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080672A1 Humanized antibody and process for preparing same
10/02/2003WO2003080671A1 Anti-rank monoclonal antibodies and pharmaceutical composition containing the same
10/02/2003WO2003080670A1 Antibody recognizing proliferative human liver cells, proliferative human liver cells and functional human liver cells
10/02/2003WO2003080669A2 Anti-hpv-16 e7 antibodies and their use
10/02/2003WO2003080665A2 Antibody that binds to a dimer of a prion protein for the treatment of tse infection
10/02/2003WO2003080663A2 Tenascin-w compositions and uses thereof
10/02/2003WO2003080655A1 A mutated immunoglobulin-binding protein
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080117A1 Methods for treating chronic obstructive pulmonary disease (copd)
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080115A1 Immunoglobulin/hydrophilic peptide complexes
10/02/2003WO2003080106A1 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003057732A3 Multispecific binding molecules
10/02/2003WO2003051910A3 Inhibitors of hepatitis c virus protease
10/02/2003WO2003050257A3 Targeting leukemia cells
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003020767A3 Antibodies against caspase-8, their preparation and use
10/02/2003WO2003016535A3 Novel amylases and uses thereof
10/02/2003WO2003010199A3 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
10/02/2003WO2003006665A8 Lawsonia intracellularis
10/02/2003WO2003006493A3 Histidine phosphatase interacting protein with 180kd
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002083160A3 Agents, which inhibit apoptosis in cells that are involved in wound healing
10/02/2003WO2002068597A3 Enzymes having alpha amylase activity and methods of use thereof
10/02/2003WO2002042432A3 Epothilone resistant cell lines
10/02/2003WO2002040047A3 Method for treating thrombocytopenia with monoclonal ivig
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002002623A3 Compositions and methods for the therapy and diagnosis of lung cancer
10/02/2003WO2001098491A3 Osteolevin gene polymorphisms
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003WO2001086307A3 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/02/2003US20030188326 Detecting cell proliferative disorders associated with breast, ovaries or prostate via monitoring mutation in gene associated with franconi anemia; antitumor/antiproliferative agents
10/02/2003US20030187247 Immunoglobulin for use in prevention and treatment of viral diseases; immunotheray; immunoassay
10/02/2003US20030187242 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187239 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187238 Comprises nucleotide sequences coding membrane proteins for use as antiproliferative/antitumor/antiinflammatory agents; drug screening
10/02/2003US20030187231 Humanized anti-TNF antibodies and peptides
10/02/2003US20030187230 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187229 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187228 Chimeric humanized monoclonal antibody for treating tumors and inflammation
10/02/2003US20030187227 Solid phase synthesis
10/02/2003US20030187225 Antibody fusion proteins: effective adjuvants of protein vaccination
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187221 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
10/02/2003US20030187197 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187196 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187195 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187193 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187192 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187191 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187190 Comprises nucleotide sequences coding membrane protein for use as antitumor/anticarcinogenic/antiinflammatory/antiproliferative agents
10/02/2003US20030187189 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/02/2003US20030187184 Viral peptide for use in diagnosis and treatment of liver disorders; genetic vaccines
10/02/2003US20030186921 Recombinant gene expression vectors and methods for use of same to enhance the immune response of a host to an antigen
10/02/2003US20030186908 Microorganisms transformed with Ig-Like polypeptide and uses thereof
1 ... 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 ... 1494